21

Brii Biosciences LtdHKG 2137 Stock Report

Last reporting period 30 Jun, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.088

Micro

Exchange

XHKG - Hong Kong Exchange

View Section: Financials

Brii Statements

21

Brii Income Statement

B

M

CNY (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2023-06-30
%

0.617

100

0

0

200.62

32514.7

104.2

16888.7

256.35

41548

-255.73

-41448

64.34

10427.9

0

-196.83

-31900.5

0

-189.92

-30780.7

-0.261

727.49

2022-12-31
%

51.626

100

0

0

180.39

349.4

84.647

164

202.07

391.4

-150.45

-291.4

26.28

50.9

0

-124.17

-240.5

0

-136.72

-264.8

-0.189

725.18

2022-06-30
%

100

0

0

257.13

0

110.84

0

357.96

0

-357.96

0

-7.653

0

0

-365.61

0

0

-347.59

0

-0.482

721.78

2021-12-31
%

100

0

0

335.65

0

140.41

0

1 232.71

0

-1 232.71

0

5.565

0

0

-1 237.51

0

0

-1 210.67

0

-7.043

171.89

2021-06-30
%

100

0

0

156.25

0

67.99

0

2 976.5

0

-2 976.5

0

44.703

0

0

-2 953.58

0

0

-2 953.18

0

-4.182

706.2

2020-12-31
%

100

0

0

874.44

0

103.4

0

1 245.46

0

-1 245.46

0

-23.139

0

0

-1 283.51

0

0

-1 189.6

0

-1.685

706.2

2020-06-30
%

100

0

0

265.74

0

41.166

0

330.98

0

-330.98

0

22.753

0

0

-308.23

0

0

-308.23

0

-0.436

706.2

View Section: Balance Sheet